Vynnychenko O, Moskalenko Y, Moskalenko R. Markers of inflammation as predictors of efficacy of trastuzumab therapy in HER2-positive metastatic breast cancer patients. Regul. Mech. Biosyst. [Internet]. 2025Jan.4 [cited 2026Jun.24];16(1):e25003. Available from: https://medicine.dp.ua/index.php/med/article/view/1163